โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT06226805RECRUITINGIRB Ready

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

(RAISE)

Sponsored by Basking Biosciences, Inc.

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...
๐Ÿ“Š
1 of 156 participants interested
1% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the investigational drug or placebo and will be followed for 90 days. A total of 156 patients are planned in this study.

Who Can Participate

Inclusion Criteria

Clinical diagnosis of acute ischemic stroke
18 years or older
Anterior circulation intra-cranial occlusion
Onset of stroke symptoms within 24 hours of enrollment

Exclusion Criteria

Large volume ischemic stroke
Intracranial hemorrhage on baseline imaging or previous intracranial hemorrhage
Chronic intracranial occlusion
Weight \>125kg
Administration of thrombolytic drug or glycoprotein IIb/IIIa inhibitors
Ongoing clinically significant coagulopathy, history of bleeding disorder or other conditions for high-risk bleeding or active uncontrolled bleeding
Prior stroke within 90 days
Unable to undergo a contrast brain perfusion scan with either MRI or CT

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

156 participants

โšง

Gender

ALL

๐Ÿข

Sponsor

Basking Biosciences, Inc.

Study Locations

Choose your preferred location or select flexible during enrollment

RECRUITING

Scottsdale

Arizona

Location available
View Scottsdale location page
WITHDRAWN

Burlingame

California

Location available
View Burlingame location page
WITHDRAWN

Long Beach

California

Location available
View Long Beach location page
WITHDRAWN

San Francisco

California

Location available
View San Francisco location page
RECRUITING

Torrance

California

Location available
View Torrance location page
RECRUITING

Jacksonville

Florida

Location available
View Jacksonville location page
RECRUITING

Detroit

Michigan

Location available
View Detroit location page
RECRUITING

St Louis

Missouri

Location available
View St Louis location page
RECRUITING

Camden

New Jersey

Location available
View Camden location page

๐Ÿ“ And 5 more locations available

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Looking for Acute Ischemic Stroke Treatment in Burlingame?

Join others in California exploring innovative treatment options through clinical research

Acute Ischemic Stroke Treatment Options in Burlingame, California

If you're searching for Acute Ischemic Stroke treatment in Burlingame, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Burlingame, Long Beach, San Francisco and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Acute Ischemic Stroke. All study-related care is provided at no cost to participants.

Local Sites
3 locations in California
Now Enrolling
Up to 156 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Acute Ischemic Stroke?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Acute Ischemic Stroke

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Acute Ischemic Stroke Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06226805. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.